These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17394438)

  • 1. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.
    Berger W; De Chandt MT; Cairns CB
    Int J Clin Pract; 2007 Apr; 61(4):663-76. PubMed ID: 17394438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group.
    Liu MC; Dubé LM; Lancaster J
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group.
    Israel E; Cohn J; Dubé L; Drazen JM
    JAMA; 1996 Mar; 275(12):931-6. PubMed ID: 8598621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors.
    Drazen J
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S233-7; discussion S247-8. PubMed ID: 9647605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allergy and leukotrienes].
    Ado VA; Mokronosova MA; Perlamutrov IuN
    Klin Med (Mosk); 1995; 73(2):9-12. PubMed ID: 7609435
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized trial of zileuton in patients with moderate asthma: effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Zileuton Study Group.
    DuBuske LM; Grossman J; Dubé LM; Swanson LJ; Lancaster JF
    Am J Manag Care; 1997 Apr; 3(4):633-40. PubMed ID: 10169531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma.
    Wenzel SE; Kamada AK
    Ann Pharmacother; 1996; 30(7-8):858-64. PubMed ID: 8826571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zileuton for asthma.
    Med Lett Drugs Ther; 1997 Feb; 39(995):18-9. PubMed ID: 9057778
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
    Woodruff PG; Albert RK; Bailey WC; Casaburi R; Connett JE; Cooper JA; Criner GJ; Curtis JL; Dransfield MT; Han MK; Harnden SM; Kim V; Marchetti N; Martinez FJ; McEvoy CE; Niewoehner DE; Reilly JJ; Rice K; Scanlon PD; Scharf SM; Sciurba FC; Washko GR; Lazarus SC;
    COPD; 2011 Feb; 8(1):21-9. PubMed ID: 21299475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.
    Malo PE; Bell RL; Shaughnessy TK; Summers JB; Brooks DW; Carter GW
    Pulm Pharmacol; 1994 Apr; 7(2):73-9. PubMed ID: 8081074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL; Young PR; Albert D; Lanni C; Summers JB; Brooks DW; Rubin P; Carter GW
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-lipoxygenase inhibitors in asthma therapy].
    Tanaka R
    Nihon Rinsho; 1996 Nov; 54(11):3040-4. PubMed ID: 8950951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zileuton: a new therapy for asthma or just the first of a new class of drugs.
    Hendeles L; Marshik PL
    Ann Pharmacother; 1996; 30(7-8):873-5. PubMed ID: 8826576
    [No Abstract]   [Full Text] [Related]  

  • 16. Zileuton.
    McGill KA; Busse WW
    Lancet; 1996 Aug; 348(9026):519-24. PubMed ID: 8757156
    [No Abstract]   [Full Text] [Related]  

  • 17. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
    Weinblatt ME; Kremer JM; Coblyn JS; Helfgott S; Maier AL; Petrillo G; Henson B; Rubin P; Sperling R
    J Rheumatol; 1992 Oct; 19(10):1537-41. PubMed ID: 1334515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
    Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
    Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABT-761 (Abbott).
    Reid JJ
    Curr Opin Investig Drugs; 2001 Jan; 2(1):68-71. PubMed ID: 11527015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.